Clinical Scorecard: Real-Time Evaluation of Intracranial Hemorrhage Detection AI Through an Ensembled Monitoring Framework

At a Glance

Key Highlights

• EMM provides real-time, case-by-case confidence assessment of black-box AI predictions without requiring ground-truth labels or internal model access
• EMM reduces cognitive burden on physicians by identifying low-confidence AI predictions and suggesting appropriate actions
• The framework improves trust and accuracy in AI-assisted intracranial hemorrhage detection and aligns with FDA guidance on AI lifecycle management

Guideline-Based Recommendations

Diagnosis

• Incorporate real-time monitoring frameworks like EMM to assess AI prediction confidence during image interpretation
• Use EMM to identify cases with low AI confidence to prompt additional review or alternative diagnostic pathways

Management

• Deploy EMM alongside primary AI models to enhance reliability and reduce misdiagnosis risk
• Apply EMM outputs to guide clinical decision-making and workflow prioritization in radiology

Monitoring & Follow-up

• Implement continuous, prospective monitoring of AI performance at point-of-care using ensemble consensus methods
• Avoid reliance solely on retrospective concordance with manual labels due to resource constraints and limited data subsets

Risks

• Recognize that unmonitored AI predictions increase cognitive workload and risk of automation and confirmation biases
• Be aware that black-box AI models without real-time confidence assessment may lead to misdiagnoses and reduced trust

Patient & Prescribing Data

Patients undergoing head CT scans for suspected intracranial hemorrhage

Use of EMM-monitored AI predictions can improve diagnostic accuracy and reduce cognitive burden on radiologists, potentially enhancing patient safety

Clinical Best Practices

• Adopt ensemble-based monitoring frameworks to provide real-time confidence metrics for black-box AI models
• Integrate EMM outputs into radiologists’ workflow to support decision-making and reduce cognitive load
• Ensure monitoring systems operate independently of AI model internals to enable deployment with commercial AI products
• Follow FDA guidance emphasizing total life-cycle management of AI tools including real-time performance monitoring
• Consider diverse sub-model architectures within EMM to robustly estimate consensus and confidence

References

• FDA Guidance on AI Total Life-Cycle Management
• Studies on AI Confidence Estimation Methods
• Automated Extraction of Diagnosis Labels from Radiology Reports